Tirzepatide and Reduced Risk of Diabetic Retinopathy and Related Complications: A Multicenter U.S. Cohort Study.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Tirzepatide and Reduced Risk of Diabetic Retinopathy and Related Complications: A Multicenter U.S. Cohort Study.
- Published In:
- Ophthalmology (2026)
- Authors:
- Shah, Jaffer, Razavi, Peyman, Festok, Muhamad, Ahmed, Harris, Mahrous, M Abdallah, Kovacs, Kyle D, Kiss, Szilárd
- Database ID:
- RPEP-16096
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-16096APA
Shah, Jaffer; Razavi, Peyman; Festok, Muhamad; Ahmed, Harris; Mahrous, M Abdallah; Kovacs, Kyle D; Kiss, Szilárd. (2026). Tirzepatide and Reduced Risk of Diabetic Retinopathy and Related Complications: A Multicenter U.S. Cohort Study.. Ophthalmology. https://doi.org/10.1016/j.ophtha.2026.01.013
MLA
Shah, Jaffer, et al. "Tirzepatide and Reduced Risk of Diabetic Retinopathy and Related Complications: A Multicenter U.S. Cohort Study.." Ophthalmology, 2026. https://doi.org/10.1016/j.ophtha.2026.01.013
RethinkPeptides
RethinkPeptides Research Database. "Tirzepatide and Reduced Risk of Diabetic Retinopathy and Rel..." RPEP-16096. Retrieved from https://rethinkpeptides.com/research/shah-2026-tirzepatide-and-reduced-risk
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.